Christof Geldmacher
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Local and systemic immune correlates of anal high-risk HPV infection and clearance in men living with HIV and men at high risk for HIV.
Journal: Frontiers in microbiology
Published: April 14, 2026
Dynamics and variant-specific patterns of SARS-CoV-2 reinfection in Ethiopia: A prospective longitudinal cohort study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 05, 2026
The use of urinary lateral-flow lipoarabinomannan assays for TB diagnosis in children.
Journal: IJTLD open
Published: October 12, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope.
Journal: bioRxiv : the preprint server for biology
Published: September 18, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025
Continuous Circulation of Hepatitis E and A Viruses During COVID-19 Pandemic Lockdowns in Munich, Germany-Experience from Three Years of Wastewater Surveillance.
Journal: Microorganisms
Published: September 01, 2025
Impact of Wuchereria bancrofti Infection on Cervical Mucosal Immunity and Human Papillomavirus Prevalence in Women from Lindi and Mbeya Regions, Tanzania.
Journal: Tropical medicine and infectious disease
Published: August 17, 2025
Host response biomarkers of tuberculosis recurrence and treatment failure.
Journal: Communications medicine
Published: May 24, 2025
Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses.
Journal: Frontiers in immunology
Published: March 28, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.
Journal: Nature immunology
Published: March 06, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.
Journal: Nature immunology
Published: March 06, 2025
Last Updated: 09/26/2026